17,520 resources
By Version
By Realm
Start Prev Rows 800 - 1000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.508 | Abdominal aortic imaging CPT | active | 2023-07 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.517 | Hemoglobin A1c | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.518 | Drug hypersensitivity I10 | active | 2023-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.519 | Drug hypersensitivity SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.520 | Drug hypersensitivity | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.521 | Diabetic Kidney Disease I10 | active | 2023-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.523 | Diabetic kidney disease | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.524 | Chronic Hepatitis SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.525 | Chronic Hepatitis | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.527 | OCS_Prednisone | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.531 | Anti IgE Medications | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.532 | IL5 Antagonists | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.533 | Mast cell stabilizers for asthma | active | 2023-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.534 | Vasospastic disease I10 | active | 2023-08 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.535 | Vasospastic disease SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.536 | Vasospastic disease | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.537 | Hemiplegic and basilar migraine I10 | active | 2023-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.538 | Hemiplegic and basilar migraine SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.539 | Hemiplegic and basilar migraine | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.540 | Peptic ulcer disease I10 | active | 2023-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.541 | Peptic ulcer disease SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.542 | Peptic ulcer disease | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.544 | Bleeding disorder I10 | active | 2023-07 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.545 | Bleeding disorder SCT | active | 2023-07 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.548 | Electronic cigarettes or Vaping | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.549 | Bleeding disorder | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.552 | Triptans | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.553 | CGRP receptor antagonists | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.554 | Ditans | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.555 | Ergots | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.556 | Migraine specific NSAIDs | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.557 | OTC migraine analgesics | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.559 | medications_migraine_acute | active | 2023-11 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.560 | relatedconditions_migraine I10 | active | 2023-08 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.561 | conditions_migraine | active | 2023-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.562 | relatedconditions_migraine SCT | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.563 | relatedconditions_migraine | active | 2023-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.564 | Triptan Allergy Intolerance SCT | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.565 | Triptan Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.566 | Ischemic bowel disease SCT | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.567 | Ischemic bowel disease I10 | active | 2023-08 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.568 | Ischemic bowel disease | active | 2023-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.573 | conditions_hyperlipidemia I10 | active | 2023-08 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.574 | conditions_hyperlipidemia SCT | active | 2023-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.575 | conditions_hyperlipidemia | active | 2023-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.578 | PIM_Schedule V | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.580 | PIM_Acarbose | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.582 | PIM_Dulaglutide | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.583 | PIM_Glimepiride | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.585 | PIM_Glucophage | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.587 | PIM_Glucovance | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.588 | Glyburide PIM | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.590 | Alpha glucosidase inhibitors | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.592 | Azotemia | active | 2023-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.594 | Intolerance to ARB SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.595 | ICS Low | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.596 | ICS Medium | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.597 | ICS High | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.598 | Low Dose ICS Formoterol | active | 2024-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.600 | PIM_Vitamin B12 Level_LOINC | active | 2023-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.601 | PIM_Vitamin B12 Level_CPT | active | 2023-09 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.604 | PIM_Glyburide | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.605 | PIM_Pioglitazone | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.606 | PIM_Semaglutide | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.607 | PIM_Linagliptin | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.609 | Macrolide_Azithromycin | active | 2023-08 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.61 | Secondary antihypertensives | active | 2023-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.610 | Long Acting Beta Agonists (LABA) Non_Formoterol | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.612 | Wolff Parkinson White SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.613 | Wolff Parkinson White I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.614 | Wolff Parkinson White | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.615 | medications_Asthma | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.619 | ICS_LABA_LAMA | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.620 | Low Dose ICS_LABA_Non Formoterol | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.621 | Medium ICS_LABA Non Formoterol | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.623 | LAMA Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.624 | LABA Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.625 | BetaBlock NonCS Secondary Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.626 | Eplerenone Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.627 | Spironolactone Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.628 | SGLT2 Inhibitors Allergy SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.629 | PIM_Refill_Request_Antilipemics_LFTs | active | 2023-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.630 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.631 | Pneumococcal Vaccine Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.632 | Meglitinides Allergy SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.633 | DPP4i Allergy SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.635 | Alpha_glucosidase inhibitors allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.636 | Glucagon_Like Peptide 1 Receptor Agonist (GLP1RA) Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.637 | Insulins Allergy SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.638 | TZD Allergy SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.639 | T2DM_Medications Allergy SCT | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.642 | T2DM_Medications Allergy RXNORM | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.643 | T2DM_Medications Allergy SNOMED | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.646 | T2DM_Medication Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.647 | Statins Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.649 | ACE Inhibitors Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.650 | ARB Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.652 | Long Acting Muscarinic Antagonists (LAMA) Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.653 | Long Acting Beta Agonists (LABA) Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.654 | BetaBlocker NonCS Secondary Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.656 | MRA Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.657 | Eplerenone Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.658 | Spironolactone Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.659 | SGLT2i Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.660 | Angiotensin Receptor Neprilysin Inhibitor(ARNI) Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.661 | Tetanus, Diphtheria, Pertusis (Tdap) Vaccine Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.665 | Tetanus toxoid, diphtheria (Td) Vaccine Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.666 | Human Papillomavirus (HPV) vaccine Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.667 | Herpes Zoster Vaccine Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.670 | Pneumococcal Vaccine Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.671 | Inhaled Corticosteroids(ICS) Allergy Intolerance | active | 2023-09 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.672 | LABA(Formoterol only) | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.674 | PIM_Tirzepatide | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.675 | GLP1RA Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.676 | PIM_Diabetes_Testing_Supplies | active | 2025-05 | us | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.677 | PIM_H2_Antagonists | active | 2023-09 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.678 | SGLT2i DM CKD | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.679 | SGLT2i DM ASCVD | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.683 | OIA_Gout_Medications | active | 2025-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.684 | GlumetzaSubstitution | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.685 | MetforminER500mg | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.686 | PIM_Metformin | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.687 | PIM_Glipizide | active | 2024-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.689 | PIM_Glipizide_Glyburide_Glimepiride | active | 2024-11 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.690 | PIM_Insulin_Meglitinides | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.691 | PIM_Glyxambi | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.692 | PIM_Farxiga | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.693 | PIM_Invokana | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.694 | PIM_Jardiance | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.695 | PIM_Invokana_Jardiance | active | 2023-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.696 | Reclast | active | 2023-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.697 | LAMA_LABA Combination 1 Inhaler | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.698 | PIM_Contraceptives | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.699 | Selected Oral Antiemetics for Migraine | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.700 | PIM_DEXA_Scan | active | 2023-12 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.701 | PIM_DEXA_Scan_CPT_LOINC | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.702 | PIM_SSRIs | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.703 | PIM_SNRIs | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.704 | PIM_NRIs | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.705 | PIM_TCAs | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.706 | PIM_Citalopram | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.707 | PIM_Hydroxyzine | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.708 | PIM_Buspirone | active | 2023-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.709 | PIM_Bupropion | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.710 | PIM_Mirtazapine | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.711 | PIM_Trazodone | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.712 | PIM_IHD_CHD_CAD_ICD10 | active | 2023-11 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.713 | PIM_IHD_CHD_CAD_SNOMED | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.714 | PIM_Gabapentin | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.715 | PIM_Allergy_Nasal_Sprays | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.716 | PIM_Allergy_Oral_Meds | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.717 | PIM_Allergy_Nasal_Oral | active | 2023-11 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.719 | OCS_Prednisolone | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.72 | Inhaled corticosteroids (IC) | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.720 | COPD_Ofloxacin | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.721 | COPD_Ciprofloxacin | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.722 | COPD_Doxycycline | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.723 | Macrolide Allergy SCT | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.724 | Macrolide Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.725 | Prednisone Allergy SCT | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.727 | Tetracycline Allergy SCT | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.728 | Tetracycline Allergy Intolerance | active | 2023-11 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.729 | Fluoroquinolones Allergy SCT | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.730 | Fluoroquinolone Allergy Intolerance | active | 2023-11 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.731 | Penicillin Allergy RXNORM | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.732 | Penicillin Allergy SCT | active | 2023-11 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.733 | Penicillin Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.734 | PIM_Metformin_Single_Ingredient_Only | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.735 | PIM_Metformin_Combo_Ingredient_Only | active | 2023-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.737 | Pneumonia SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.738 | Pneumonia | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.739 | Pulmonary Embolism I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.742 | Pulmonary Embolism SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.743 | Pulmonary Embolism | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.744 | Influenza I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.745 | Influenza SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.746 | Influenza (Tests for influenza A or B virus Antigen) | active | 2023-12 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.747 | Influenza | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.748 | COVID 19 I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.749 | COVID19 SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.750 | COVID19 | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.752 | RSV I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.753 | RSV SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.754 | RSV | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.755 | Respiratory Rate SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.756 | Respiratory Rate LOINC | active | 2024-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.757 | Respiratory Rate | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.758 | Acute Respiratory Failure I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.759 | Acute Respiratory Failure SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.760 | Acute Respiratory Failure | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.761 | Dyspnea SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.762 | Dyspnea I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.763 | Dyspnea | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.764 | Confusion I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.765 | Confusion SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.766 | Confusion | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.767 | Drowsiness SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.768 | Drowsiness I10 | active | 2023-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.769 | Drowsiness | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.770 | Cyanosis I10 | active | 2023-12 | us | icd |